Display options
Cite
Horga G, Wengler K, Cassidy CM. Neuromelanin-Sensitive Magnetic Resonance Imaging as a Proxy Marker for Catecholamine Function in Psychiatry. JAMA Psychiatry. 2021;78(7):788-789doi: 10.1001/jamapsychiatry.2021.0927.
Horga, G., Wengler, K., & Cassidy, C. M. (2021). Neuromelanin-Sensitive Magnetic Resonance Imaging as a Proxy Marker for Catecholamine Function in Psychiatry. JAMA psychiatry, 78(7), 788-789. https://doi.org/10.1001/jamapsychiatry.2021.0927
Horga, Guillermo, et al. "Neuromelanin-Sensitive Magnetic Resonance Imaging as a Proxy Marker for Catecholamine Function in Psychiatry." JAMA psychiatry vol. 78,7 (2021): 788-789. doi: https://doi.org/10.1001/jamapsychiatry.2021.0927
Horga G, Wengler K, Cassidy CM. Neuromelanin-Sensitive Magnetic Resonance Imaging as a Proxy Marker for Catecholamine Function in Psychiatry. JAMA Psychiatry. 2021 Jul 01;78(7):788-789. doi: 10.1001/jamapsychiatry.2021.0927. PMID: 34009285.
Copy Download .nbib Format: NLM
Share it on

JAMA Psychiatry. 2021 Jul 01;78(7):788-789. doi: 10.1001/jamapsychiatry.2021.0927.

Neuromelanin-Sensitive Magnetic Resonance Imaging as a Proxy Marker for Catecholamine Function in Psychiatry.

JAMA psychiatry

Guillermo Horga, Kenneth Wengler, Clifford M Cassidy

Affiliations

  1. Department of Psychiatry, Columbia University, New York, New York.
  2. Division of Translational Imaging, New York State Psychiatric Institute, New York.
  3. University of Ottawa Institute of Mental Health Research, The Royal Ottawa Mental Health Center, Ottawa, Ontario, Canada.

PMID: 34009285 DOI: 10.1001/jamapsychiatry.2021.0927

[No abstract available.]

Publication Types